SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nakoda Group of Industries Ltd

Industry : Food - Processing - Indian

BSE Code

ISIN Demat

Book Value()

541418

INE236Y01012

19.8256066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NGIL

65.68

EPS(TTM)

Face Value()

Div & Yield %

Back

square four projects india ltd

Oxygenta Pharmaceutical reports standalone net loss of Rs 4.84 crore in the December 2025 quarter

Feb 05,2026

Net Loss of Oxygenta Pharmaceutical reported to Rs 4.84 crore in the quarter ended December 2025 as against net loss of Rs 3.93 crore during the previous quarter ended December 2024. Sales rose 2.17% to Rs 33.93 crore in the quarter ended December 2025 as against Rs 33.21 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	33.93	33.21	2
OPM %	-12.00	-13.10	-
PBDT	-5.46	-4.25	-28
PBT	-6.32	-4.96	-27
NP	-4.84	-3.93	-23

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)